Characteristics of the 55 Patients Receiving an Allogeneic Stem Cell Transplantation for AMM
. | Marrow Fibrosis . | Overall Group n = 55 . | |
---|---|---|---|
Grade I-II n = 28 . | Grade III n = 27 . | ||
Age at diagnosis | |||
>40 yr | 13 | 8 | 21 |
Hemoglobin ≤100 g/L at diagnosis | 8 | 9 | 17 |
Blasts in peripheral blood at diagnosis | 9 | 11 | 20 |
Intermediate- + high-risk scores at diagnosis* | 10 | 11 | 21 |
Cytogenetic abnormalities before transplant | 8 | 5 | 13 |
Treatments before transplant | |||
None | 8 | 5 | 13 |
Chemotherapy | 13 | 15 | 28 |
Other treatments | 8 | 12 | 20 |
Splenectomy | 12 | 15 | 27 |
Transfusions before transplant | |||
RBC transfusions | 16 | 20 | 36 |
10 or more RBC units transfused | 10 | 12 | 22 |
Platelet transfusions | 6 | 5 | 11 |
Age at transplant (yr) | |||
<40 | 10 | 15 | 25 |
≥40 | 18 | 12 | 30 |
≥44 | 15† | 8 | 23 |
≥48 | 8 | 3 | 11 |
Time from diagnosis to transplant (mo) | |||
<24 | 19‡ | 12 | 31 |
≥24 | 9 | 15 | 24 |
≥48 | 6 | 9 | 15 |
Hemoglobin ≤100 g/L at transplant | 15 | 20 | 35 |
Blasts in peripheral blood at transplant | 6 | 11 | 17 |
Intermediate- + high-risk scores at transplant* | 19 | 23 | 42 |
. | Marrow Fibrosis . | Overall Group n = 55 . | |
---|---|---|---|
Grade I-II n = 28 . | Grade III n = 27 . | ||
Age at diagnosis | |||
>40 yr | 13 | 8 | 21 |
Hemoglobin ≤100 g/L at diagnosis | 8 | 9 | 17 |
Blasts in peripheral blood at diagnosis | 9 | 11 | 20 |
Intermediate- + high-risk scores at diagnosis* | 10 | 11 | 21 |
Cytogenetic abnormalities before transplant | 8 | 5 | 13 |
Treatments before transplant | |||
None | 8 | 5 | 13 |
Chemotherapy | 13 | 15 | 28 |
Other treatments | 8 | 12 | 20 |
Splenectomy | 12 | 15 | 27 |
Transfusions before transplant | |||
RBC transfusions | 16 | 20 | 36 |
10 or more RBC units transfused | 10 | 12 | 22 |
Platelet transfusions | 6 | 5 | 11 |
Age at transplant (yr) | |||
<40 | 10 | 15 | 25 |
≥40 | 18 | 12 | 30 |
≥44 | 15† | 8 | 23 |
≥48 | 8 | 3 | 11 |
Time from diagnosis to transplant (mo) | |||
<24 | 19‡ | 12 | 31 |
≥24 | 9 | 15 | 24 |
≥48 | 6 | 9 | 15 |
Hemoglobin ≤100 g/L at transplant | 15 | 20 | 35 |
Blasts in peripheral blood at transplant | 6 | 11 | 17 |
Intermediate- + high-risk scores at transplant* | 19 | 23 | 42 |